Description: Avrobio Inc is a clinical stage gene therapy company. It is engaged in the development of potentially curative ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose.
Home Page: www.avrobio.com
AVRO Technical Analysis
Building 300
Cambridge,
MA
02139
United States
Phone:
617 914 8420
Officers
| Name | Title |
|---|---|
| Mr. Geoff MacKay BSc | Co- Founder, Pres, CEO & Director |
| Mr. Erik John Ostrowski M.B.A. | CFO & Treasurer |
| Mr. Jeffrey Medin Ph.D. | Scientific Founder |
| Mr. Matthew Arnold | Head of Operations |
| Mr. Steven N. Avruch J.D. | Chief Legal Officer & Sec. |
| Ms. Monique Da Silva | Sr. VP of Corp. Communications |
| Ms. Deanna M. Petersen MBA | Chief Bus. Officer |
| Ms. Azadeh Golipour Ph.D. | Chief Technology Officer |
| Mr. Andreas Kouri | Sr. VP of Global Supply Chain & External Manufacturing |
| Dr. Essra Ridha FFPM, M.D. | Chief Medical Officer |
Exchange: NASDAQ
Country: US
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0.3548 |
| Price-to-Sales TTM: | 0 |
| IPO Date: | 2018-06-21 |
| Fiscal Year End: | December |
| Full Time Employees: | 122 |